2/2
The developed methods include AI image analysis drug screening, a novel organoid microarray and HTS reverse-phase-protein-arrays for modelling immunotherapy efficacy.
1/2
Juha’s fellowship focussed on ex vivo drug screening technology for functional diagnostic assessment of patient-specific efficacy of targeted cancer therapies.
Robin's fellowship focussed on developing the early phase trials portfolio, especially in lung cancer. He is now a very research active NHS Consultant, with interests in lung cancer, sarcoma, germ cell tumours, Teenage and Young Adults (TYA) and early phase clinical trials.
Matt’s fellowship has focused on evaluating the potential role of immunotherapy in the low-risk treatment of gestational trophoblastic neoplasia and further developing a valuable international database.
Satya’s research is focussed on the use of PETMRI scans in radiotherapy planning of head and neck cancer patients. An early phase study checks the feasibility of obtaining PETMRI scans with immobilisation and to assess the impact of additional imaging on the accuracy of planning.
Sarah was a YCR CONNECTS fellow from 2020-2022, additionally being awarded a Churchill Fellowship (2020) to research new ways to improve palliative care in the primary health sector. She was appointed Associate Professor of Palliative Care at the University of Leeds in 2022.
Sarah’s research focussed on the role and response of primary care in COVID-19 end-of-life care, improving identification of palliative care needs, the integration of palliative care services in the community to reduce inequalities, and paediatric palliative care #palliativecare
Immunotherapy has brought huge survival benefits to the treatment of melanoma. It is increasingly used but little is known about the long-term effects, which can be life-changing. Jo’s research is focussed on these ��Late effects’ and the experience and support needs of patients.
Andy has also developed novel strategies to target myeloma tumour including the development of a myeloma specific oncolytic adeno-viral construct. (2/2)
@andrew_chantry @ShefUni_ClinMed @TUOS_Cancer
Andy’s research has focused on the use of bone anabolic agents in myeloma bone disease. Using an anti Dkk1 antibody and by targeting the TGF-beta pathway, he has demonstrated substantial protection against osteolytic bone disease in myeloma. (1/2) @andrew_chantry @ShefUni_ClinMed
Catriona’s fellowship has focused on improving the integration of palliative care within cancer care, providing support throughout the illness, including during bereavement, and exploring ways to recognise and reduce inequities #hapc#PalliativeCare#hpm@CattyRM
Lung cancer is Yorkshire’s most common cancer. Many patients are excluded from treatment or at risk of lung damage because of poor respiratory function. Bilal’s fellowship aims to change this through developing innovative scanning methods for functional image-guided therapy.
How best to decide which new cancer treatments get funded? Nick's fellowship aims to benefit patients by improving the use of patient data from clinical trials so that we can make better decisions on which cancer treatments to prioritise. @NRLatimer @ShefUni_ClinMed @TUOS_Cancer
Yorkshire Cancer Research (YCR) CONNECTS fellowship has 4 strategic areas: Early diagnosis and access to treatment; Improving clinical outcomes in common malignancies; Lung cancer; and Improved health and wellbeing with and beyond cancer @TUOS_Cancer @ShefUni_ClinMed
The Yorkshire Cancer Research (YCR) CONNECTS fellowship scheme wants to change that Yorkshire is one of the regions hardest hit by cancer. #cancerresearch@TUOS_Cancer @ShefUni_ClinMed
🗣️Calling all clinical researchers – @CRUK_Policy is running a survey to hear about your experience working in #ClinicalResearch, including the barriers & challenges that need addressing by Government. Complete the survey by 9 August 👇
https://t.co/LwbJKXABHe
@MacGPSarah will be presenting at the Cicely Saunders Institute Open Seminar Series on Thursday 23rd March. Get your ticket here for her online talk: https://t.co/zDuqSub17F
@cicelysaunders1
Have you got ideas that could enable earlier detection & diagnosis of cancer? Our Primer Award funds exploratory research and collaboration building. You don't need to be a senior researcher or have a track record in the field to apply.
Apply by 10 March: https://t.co/YxHLvNpVFN
As today is World Cancer Day, it seems like the perfect time to put together a thread of some of the most groundbreaking cancer research from @sheffielduni. Take a look at some of our highlights in the thread below! 👇#WorldCancerDay